Clara Santos-Cuevas

16PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapyMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 30, 2025
Synthesis and Evaluation of [18F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [177Lu]Lu-DOTA-iPD-L1.

Guillermina Ferro-Flores, Myrna Luna-Gutiérrez, Blanca Ocampo-García

|Nov 27, 2024
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study.

Sofía González-Rueda, Osvaldo García-Pérez, Myrna Luna-Gutiérrez

|Apr 27, 2024
68Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases.

Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, José G Aguirre-De Paz

|Dec 23, 2023
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.

Guillermina Ferro-Flores, Blanca Ocampo-García, Pedro Cruz-Nova

|Dec 09, 2023
225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins.

Blanca Ocampo-García, Pedro Cruz-Nova, Nallely Jiménez-Mancilla

|Aug 12, 2023
Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy.

Myrna Luna-Gutiérrez, Pedro Cruz-Nova, Nallely Jiménez-Mancilla

Pageof 3